Inventor
THORBERG SETH-OLOV
SE34 patents
⚠️ This page may combine multiple inventors who share the name “THORBERG SETH-OLOV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRA AB
15 patentsUS5420151AMay 30, 1995
Chroman derivatives
ASTRA AB38 citations92
US6184219B1Feb 6, 2001
Composition and methods employing it for the treatment of 5-HT-mediated disorders
ASTRA AB19 citations91
US5962514AOct 5, 1999
Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist
ASTRA AB22 citations91
US6172105B1Jan 9, 2001
Composition and methods employing it for the treatment of 5-HT-mediated disorders
ASTRA AB10 citations81
US5656658AAug 12, 1997
Method for the treatment of anxiety
ASTRA AB9 citations80
US5639772AJun 17, 1997
Chroman derivatives
ASTRA AB13 citations80
US6184218B1Feb 6, 2001
Composition and methods employing it for the treatment of 5-HT-mediated disorders
ASTRA AB5 citations72
US6124283ASep 26, 2000
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRA AB7 citations72
US5656657AAug 12, 1997
Chroman derivatives
ASTRA AB5 citations71
US5646309AJul 8, 1997
Intermediates in the synthesis of chroman derivatives
ASTRA AB5 citations70
US5500425AMar 19, 1996
Chroman derivatives and a method of treating 5-HT mediated disorders
ASTRA AB3 citations69
US6169098B1Jan 2, 2001
Composition and methods employing it for the treatment of 5-HT-mediated disorders
ASTRA AB2 citations61
US6313118B1Nov 6, 2001
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRA AB4 citations60
US5641807AJun 24, 1997
Method for the treatment of depression
ASTRA AB1 citations60
US5639784AJun 17, 1997
Method for the treatment of migraine
ASTRA AB2 citations60
ASTRAZENECA AB
14 patentsUS6479497B1Nov 12, 2002
Substituted chroman derivatives
ASTRAZENECA AB16 citations92
US6472423B1Oct 29, 2002
Pharmaceutical composition
ASTRAZENECA AB24 citations92
US6159971ADec 12, 2000
Combination of a 5-HT reuptake inhibitor and a h5-HT1B anatagonist or partial agonist
ASTRAZENECA AB26 citations92
US6387899B1May 14, 2002
Substituted chroman derivatives
ASTRAZENECA AB18 citations90
US6159970ADec 12, 2000
Combination of a monoamine oxidase inhibitor and a h5-HT1B antagonist or partial agonist
ASTRAZENECA AB7 citations73
US6384225B1May 7, 2002
Intermediates in the preparation of substituted chroman derivatives
ASTRAZENECA AB7 citations71
US6159972ADec 12, 2000
Combination of a selective 5-HT1A antagonist and a selective ub. h5-HT.s1B antagonist or partial agonist
ASTRAZENECA AB6 citations62
US6548498B1Apr 15, 2003
Substituted indan derivatives
ASTRAZENECA AB2 citations61
US6534652B2Mar 18, 2003
Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB0 citations52
US6410532B2Jun 25, 2002
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB0 citations52
US7384943B2Jun 10, 2008
Substituted chroman derivatives
ASTRAZENECA AB0 citations51
US6670359B2Dec 30, 2003
Substituted chroman derivatives
ASTRAZENECA AB0 citations51
US7439356B2Oct 21, 2008
Substituted indan derivatives
ASTRAZENECA AB0 citations50
US6410530B1Jun 25, 2002
Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ASTRAZENECA AB1 citations50
ASTRA LAEKEMEDEL AB
4 patentsUS4073941AFeb 14, 1978
Aralkyl amides having antidepressive activity
ASTRA LAEKEMEDEL AB8 citations71
US4098901AJul 4, 1978
Trifluoromethyl substituted compounds having antidepressive activity
ASTRA LAEKEMEDEL AB2 citations60
US4237311ADec 2, 1980
2-Methyl-1-(substituted)phenyl-2-propyl esters of 2-aminopropanoic acid
ASTRA LAEKEMEDEL AB3 citations54
US4331684AMay 25, 1982
Compounds having antidepressive activity
ASTRA LAEKEMEDEL AB1 citations48